WLFDY yields 67.73% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 10
Combined, WLFDY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WLFDY + PFE for your $10,000?
Wolford Aktiengesellschaft produces and markets legwear, ready-to-wear garments, lingerie, beachwear, and accessories in Austria, Germany, France, the United Kingdom, Ireland, rest of Europe, North America, and Asia/Oceania. Its legwear products include pantyhose, tights, leggings, stay-ups, knee-highs, and socks; and lingerie comprises bras, briefs, bodies, garter belts, and slips. The company's ready-to-wear products include sweaters, dresses, skirts, and trousers; accessories comprise scarves and belts; and beachwear products include swimsuits and bikinis. It also offers bodysuits and close-fitting knitwear, such as tops and shirts. The company sells its products through boutiques, concession shop-in-shops, online business, factory outlets, department stores, specialist retail stores, and private label. As of December 31, 2021, it had 229 monobrand points of sales, which include 101 boutiques, 48 concession shop-in-shops, and 18 factory outlets owned by the company; 62 partners-operated boutiques; and approximately 2,500 other distribution partners. The company was founded in 1950 and is headquartered in Bregenz, Austria. Wolford Aktiengesellschaft is a subsidiary of Fosun Industrial Holdings Limited.
Full WLFDY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.